Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients

  • Jiusheng Deng J
N/ACitations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE: B cell targeted therapies have been effective in slowing multiple sclerosis (MS) disease progression suggesting a direct causal link for this lymphoid subset. A small subset of B cells with regulative properties (Bregs) exists in peripheral blood, and induction of Bregs ameliorates experimental autoimmune encephalomyelitis (EAE), the murine model for MS. Therefore the frequency of B cell subsets and regulatory B cells in particular in peripheral blood of MS patients is of interest. METHODS: The phenotype and frequency of B cell subsets in peripheral blood from 32 MS patients and 34 healthy controls (HC) were examined using flow cytometry. RESULTS: We found that there is an increase in CD19+ cell number in MS 1347 +/- 159 cells/muL, (average +/- SEM) compared to HC, 935 +/- 129 cells/muL and no apparent deficiency in B-cells with a regulatory phenotype. In addition, we observed a loss of correlation between CD19+ B cells and total lymphocyte count in MS. CONCLUSION: These findings suggest altered blood B-cell homeostasis in MS patients.

Cite

CITATION STYLE

APA

Jiusheng Deng, J. H. (2015). Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients. Journal of Multiple Sclerosis, 02(02). https://doi.org/10.4172/2376-0389.1000139

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free